Fibromyalgia & musculoskeletal pain

Suitability of the Numerical Pain Rating Scale for measuring pain in clinical trials evaluating interventions for people with shoulder disorders according to the OMERACT filter 2.2

Semin Arthritis RheumPublished Systematic review

Authors' conclusion

The NPRS cannot progress to the endorsement stage for the core domain of pain for shoulder conditions due to insufficient evidence for any single NPRS version.

Study context

Population
Studies evaluating the Numerical Pain Rating Scale (NPRS) for measuring pain in people with shoulder disorders12 studies, 18 pieces of evidence
Outcome
Suitability of the NPRS for measuring pain (construct validity, reliability, longitudinal construct validity, clinical trial discrimination, thresholds of meaning) per OMERACT Filter 2.2
Methodological detailsOMERACT Filter 2.2, COSMIN-OMERACT Good Methods Checklist, consensus vote at 2025 OMERACT Shoulder Special Interest Group workshop
  • OMERACT Filter 2.2
  • COSMIN-OMERACT Good Methods Checklist
  • Consensus vote at 2025 OMERACT Shoulder Special Interest Group workshop

Pooled result

As reported in the abstract

Measurement-property evidence for the NPRS
Studies examining construct validity
3
Studies examining test-retest reliability
2
Studies examining longitudinal construct validity
4
Studies examining clinical trial discrimination
6
Studies examining thresholds of meaning
3
Components of evidence rated green (good methods)
6 (33%)
Components of evidence rated amber
12

Further pooled results

Workshop vote: synthesizing results from studies using different NPRSs inappropriate

Respondents agreeing
75%

Original publication

Suitability of the Numerical Pain Rating Scale for measuring pain in clinical trials evaluating interventions for people with shoulder disorders according to the OMERACT filter 2.2. Semin Arthritis Rheum. Published 20 February 2026. doi:10.1016/j.semarthrit.2026.152954

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.